ESSA Pharma Inc. (NASDAQ:EPIX – Get Free Report) (TSE:EPI)’s share price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $5.96 and traded as low as $5.01. ESSA Pharma shares last traded at $5.20, with a volume of 27,568 shares trading hands.
ESSA Pharma Price Performance
The business has a fifty day moving average price of $5.88 and a two-hundred day moving average price of $5.70. The firm has a market capitalization of $62.12 million, a price-to-earnings ratio of -2.26 and a beta of 1.83.
ESSA Pharma (NASDAQ:EPIX – Get Free Report) (TSE:EPI) last posted its earnings results on Monday, August 5th. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.10. On average, research analysts predict that ESSA Pharma Inc. will post -0.71 earnings per share for the current year.
Hedge Funds Weigh In On ESSA Pharma
About ESSA Pharma
ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company’s lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.
Featured Articles
- Five stocks we like better than ESSA Pharma
- Most Volatile Stocks, What Investors Need to Know
- Battle of the Retailers: Who Comes Out on Top?
- The Significance of Brokerage Rankings in Stock Selection
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Dividend Capture Strategy: What You Need to Know
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.